Combination Therapy in Pulmonary Arterial Hypertension

被引：9

作者：

Channick, Richard N. ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Med, Pulm Hypertens & Thromboendarterect Program, Boston, MA USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 08期

关键词：

CONTINUOUS INTRAVENOUS EPOPROSTENOL; SMOOTH-MUSCLE-CELLS; INHALED ILOPROST; BOSENTAN THERAPY; ORAL SILDENAFIL; EFFICACY; TREPROSTINIL; SURVIVAL; TRIAL; PROSTACYCLIN;

D O I：

10.1016/j.amjcard.2013.01.320

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Many potential therapeutic options are now available for patients with pulmonary arterial hypertension. Interest has emerged in using therapies in various combinations. Retrospective experience has suggested that this approach is common and can be efficacious. Data are emerging supporting the benefit of combination therapy; however, limitations and questions remain about this strategy. This report reviewed the rationale for combination therapy and summarized the results from clinical trials. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111[suppl]:16C-20C)

引用

页码：16C / 20C

页数：5

共 38 条

[1] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[4] SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].

BARST, RJ ;

RUBIN, LJ ;

MCGOON, MD ;

CALDWELL, EJ ;

LONG, WA ;

LEVY, PS .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415

[5] Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan [J].

Barst, Robyn J. ;

Langleben, David ;

Badesch, David ;

Frost, Adaani ;

Lawrence, E. Clinton ;

Shapiro, Shelley ;

Naeije, Robert ;

Galie, Nazzareno .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) :2049-2056

[6] Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension [J].

Barst, Robyn J. ;

Gibbs, J. Simon R. ;

Ghofrani, Hossein A. ;

Hoeper, Marius M. ;

McLaughlin, Vallerie V. ;

Rubin, Lewis J. ;

Sitbon, Olivier ;

Tapson, Victor F. ;

Galie, Nazzareno .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) :S78-S84

[7] Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease [J].

Benza, RL ;

Rayburn, BK ;

Tallaj, JA ;

Coffey, CS ;

Pinderski, LJ ;

Parnoukian, SV ;

Bourge, RC .

CHEST, 2006, 129 (04) :1009-1015

[8] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension [J].

Channick, Richard N. ;

Olschewski, Horst ;

Seeger, Werner ;

Staub, Ted ;

Voswinckel, Robert ;

Rubin, Lewis J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) :1433-1437

[9] Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan [J].

Faruqi, S. ;

Fathi, H. ;

Morice, A. H. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (03) :E43-E45

[10] The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States How REVEAL Differs From Historic and Non-US Contemporary Registries [J].

Frost, Adaani E. ;

Badesch, David B. ;

Barst, Robyn J. ;

Benza, Raymond L. ;

Elliott, Gregory ;

Farber, Harrison W. ;

Krichman, Abby ;

Liou, Theodore G. ;

Raskob, Gary E. ;

Wason, Prieya ;

Feldkircher, Kathleen ;

Turner, Michelle ;

McGoon, Michael D. .

CHEST, 2011, 139 (01) :128-137

← 1 2 3 4 →